Unlikely to cause harm — often a labeling or packaging issue.
Failed Dissolution Specifications
| Brand name | TROKENDI XR |
| Generic name | TOPIRAMATE |
| Active ingredient(s) | TOPIRAMATE |
| Distributed by / for | Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA |
| NDC | 17772-101-30 |
| Full product label | Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-101-30. |
| Recalling firm | Supernus Pharmaceuticals, Inc. |
| Distribution | US Nationwide. |
| Quantity | 15,853 bottles |
| Recall initiated | 2026-07-06 |
| Report date | 2026-07-29 |
| Recall completed | — |
| Recall number | D-0758-2026 |
| Classification | Class III |
| FDA status | Ongoing |
| Origin on file | Rockville MD United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗